Andlauer Historical Cash Flow
| AND Stock | CAD 42.80 0.16 0.38% |
Analysis of Andlauer Healthcare cash flow over time is an excellent tool to project Andlauer Healthcare future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Begin Period Cash Flow of 44.4 M or Depreciation of 41 M as it is a great indicator of Andlauer Healthcare ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Andlauer Healthcare latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Andlauer Healthcare is a good buy for the upcoming year.
Andlauer |
About Andlauer Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Andlauer balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Andlauer's non-liquid assets can be easily converted into cash.
Andlauer Healthcare Cash Flow Chart
Add Fundamental
Free Cash Flow
The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Dividends Paid
The total amount of dividends that a company has paid out to its shareholders over a specific period.Most accounts from Andlauer Healthcare's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Andlauer Healthcare current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Andlauer Healthcare Gr. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, Andlauer Healthcare's Dividends Paid is very stable compared to the past year. As of the 23rd of November 2024, Capital Expenditures is likely to grow to about 26.9 M, though Change To Inventory is likely to grow to (1.9 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Capital Expenditures | 9.7M | 28.0M | 25.6M | 26.9M | Dividends Paid | 7.9M | 10.9M | 14.2M | 19.6M |
Andlauer Healthcare cash flow statement Correlations
Click cells to compare fundamentals
Andlauer Healthcare Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Andlauer Healthcare cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | 295K | (157K) | (472K) | (317K) | (2.0M) | (1.9M) | |
| Investments | (6.2M) | (20.4M) | (7.6M) | (45.6M) | (23.8M) | (25.0M) | |
| Change In Cash | (34.9M) | 11.4M | (5.2M) | 40.9M | (6.1M) | (5.8M) | |
| Net Borrowings | (176.4M) | (24.7M) | 10.9M | (40.0M) | (36.0M) | (37.8M) | |
| Free Cash Flow | 54.8M | 45.6M | 74.4M | 109.2M | 78.8M | 64.8M | |
| Change In Working Capital | 3.1M | (11.6M) | (6.3M) | (3.1M) | (26.9M) | (25.6M) | |
| Begin Period Cash Flow | 53.7M | 18.7M | 30.1M | 25.0M | 65.9M | 44.4M | |
| Total Cashflows From Investing Activities | (6.2M) | (20.4M) | (183.4M) | (45.6M) | (41.0M) | (43.1M) | |
| Other Cashflows From Financing Activities | 26.1M | 13.4M | 101.9M | (11.7M) | (188K) | (178.6K) | |
| Depreciation | 25.7M | 28.0M | 42.7M | 64.5M | 68.1M | 41.0M | |
| Other Non Cash Items | 107K | 96K | (40.4M) | 221K | 570K | 541.5K | |
| Dividends Paid | 112.0M | 7.9M | 7.9M | 10.9M | 14.2M | 19.6M | |
| Capital Expenditures | 6.2M | 5.4M | 9.7M | 28.0M | 25.6M | 26.9M | |
| Total Cash From Operating Activities | 61.0M | 51.0M | 84.1M | 137.1M | 104.4M | 77.3M | |
| Change To Account Receivables | (2.6M) | (3.0M) | (10.1M) | (2.9M) | (4.1M) | (4.3M) | |
| Change To Operating Activities | (1.1M) | (269K) | (121K) | 327K | 294.3K | 309.0K | |
| Net Income | 30.3M | 37.7M | 90.0M | 76.3M | 66.1M | 51.2M | |
| Total Cash From Financing Activities | (89.8M) | (19.2M) | 93.9M | (51.6M) | (86.2M) | (81.9M) | |
| End Period Cash Flow | 18.7M | 30.1M | 25.0M | 65.9M | 59.7M | 46.4M | |
| Change To Netincome | 2.4M | (3.1M) | (42.6M) | (792K) | (712.8K) | (748.4K) | |
| Change To Liabilities | (2.2M) | (948K) | 4.4M | 1.5M | 1.7M | 869.9K |
Other Information on Investing in Andlauer Stock
The Cash Flow Statement is a financial statement that shows how changes in Andlauer balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Andlauer's non-liquid assets can be easily converted into cash.